If a person is taking corticosteroids or immunosuppressants, those drugs should be stopped before starting<unk>  because they may interfere with<unk> ; they may be used after<unk>  is started to deal with immune-related adverse effects. Women of child-bearing age should use contraception when taking<unk> ; it should not be administered to pregnant women because animal studies have shown that it can reduce tolerance to the fetus, increasing the risk of miscarriage. It is not known whether<unk>  is present in breast milk. , the drug had not been tested in people with active infections (including any HIV, hepatitis B or hepatitis C infection), kidney or liver disease, active Central nervous system (CNS) metastases, active systemic autoimmune disease, interstitial lung disease, prior pneumonia, and people with a history of severe reaction to another monoclonal antibody.
Pembrolizumab
Nivolumab
Afatinib
Ipilimumab
Loncastuximab tesirine
Acalabrutinib
Imatinib
Sorafenib